INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 283 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $488 | -99.9% | 14 | 0.0% | 0.00% | – |
| Q3 2022 | $783,000 | +8.0% | 14 | 0.0% | 0.00% | – |
| Q2 2022 | $725,000 | -28.7% | 14 | 0.0% | 0.00% | – |
| Q1 2022 | $1,017,000 | -38.5% | 14 | 0.0% | 0.00% | – |
| Q4 2021 | $1,655,000 | -11.9% | 14 | 0.0% | 0.00% | – |
| Q3 2021 | $1,878,000 | -17.2% | 14 | 0.0% | 0.00% | – |
| Q2 2021 | $2,267,000 | +101.7% | 14 | 0.0% | 0.00% | – |
| Q1 2021 | $1,124,000 | +47.5% | 14 | 0.0% | 0.00% | – |
| Q4 2020 | $762,000 | +174.1% | 14 | 0.0% | 0.00% | – |
| Q3 2020 | $278,000 | -5.4% | 14 | 0.0% | 0.00% | – |
| Q2 2020 | $294,000 | +71.9% | 14 | 0.0% | 0.00% | – |
| Q1 2020 | $171,000 | -16.6% | 14 | 0.0% | 0.00% | – |
| Q4 2019 | $205,000 | – | 14 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,615,321 | $23,697,000 | 41.29% |
| ARK Investment Management | 8,741,432 | $128,237,000 | 3.23% |
| Nikko Asset Management Americas, Inc. | 7,178,520 | $105,309,000 | 1.66% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $1,635,000 | 0.86% |
| Elmwood Wealth Management, Inc. | 64,204 | $942,000 | 0.82% |
| 361 CAPITAL LLC | 94,772 | $1,390,000 | 0.38% |
| Artal Group S.A. | 199,700 | $2,930,000 | 0.11% |
| StoneX Group Inc. | 14,982 | $220,000 | 0.09% |
| Sumitomo Mitsui Trust Holdings, Inc. | 7,178,520 | $105,309,000 | 0.08% |
| PDT Partners, LLC | 85,517 | $1,255,000 | 0.08% |